Concepedia

Sabari Nath Neerukonda

SN

Statistics

Publications

20

Citations

713

H-Index

15

Active since

2010

Affiliations

Center for Biologics Evaluation and Research(Current)

United States Food and Drug Administration

National Institute of Allergy and Infectious Diseases

Biomedical Advanced Research and Development Authority

Office of Readiness and Response

Sabari Nath Neerukonda is an author at Center for Biologics Evaluation and Research specializing in infectious diseases, molecular virology, and sars-cov-2 infection.

ORCID

Publications per year

2010–2023

20

Publications

20

Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2

Sabari Nath Neerukonda, Russell Vassell, Rachel Herrup et al. · PLoS ONE · 2021 · 143 citations · Full text

, , +12

SARS-CoV-2 BA.1 variant is neutralized by vaccine booster–elicited serum but evades most convalescent serum and therapeutic antibodies

Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda et al. · Science Translational Medicine · 2022 · 95 citations · Full text

, , +17

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 60 citations · Full text

, , +15

SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster

Sabrina Lusvarghi, Simon Pollett, Sabari Nath Neerukonda et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 44 citations · Full text

, , +16

Comparison of exosomes purified via ultracentrifugation (UC) and Total Exosome Isolation (TEI) reagent from the serum of Marek’s disease virus (MDV)-vaccinated and tumor-bearing chickens

Sabari Nath Neerukonda, Nicholas A. Egan, Joseph N. Patria et al. · Journal of Virological Methods · 2018 · 41 citations

, , +11

1–5 of 20